Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES SWEGON (1) (1) (1)
Mandate

VINGE ADVISES SWEGON

June 09, 2014

Vinge has advised Swegon AB in connection with its acquisition of the Canadian company, Vibro-Acoustics®. Vibro-Acoustics® is a leading producer of acoustic ventilation products and vibration reduction products in North America.

Vibro-Acoustics was established in 1960 and its head office is situated in Toronto. In addition to Toronto, the company also has manufacturing facilities in Nashville and Reno. The company has 167 employees and had a turnover in 2013 of MCAD 28, equivalent to approximately SEK 170 million. Swegon AB is a market-leading producer and supplier of energy efficient ventilation and climate control systems. Swegon AB is a wholly-owned subsidiary of Investment AB Latour.

Swegon was advised by advokat Magnus Pauli.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026